NCT03585868

Brief Summary

The study use a double blind, placebo-controlled design enrolling male and female subjects between 55-90 yo to evaluate the effect of daily consumption of a cocoa beverage on anthropometric, metabolic, oxidative stress, physical performance and quality of life.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 13, 2018

Completed
Last Updated

July 13, 2018

Status Verified

July 1, 2018

Enrollment Period

9 months

First QC Date

May 16, 2018

Last Update Submit

July 12, 2018

Conditions

Keywords

flavonoids

Outcome Measures

Primary Outcomes (7)

  • Blood glucose

    Fasting blood level

    At 90 days

  • Serum triacylglycerol concentration

    Fasting blood level

    At 90 days

  • Serum total cholesterol

    Fasting blood level

    At 90 days

  • Serum HDL cholesterol

    Fasting blood level

    At 90 days

  • Serum LDL cholesterol

    Fasting blood level

    At 90 days

  • Lipid oxidation

    Serum malondialdehyde Levels

    At 90 days

  • Protein oxidation

    Serum protein carbonylation Levels

    At 90days

Secondary Outcomes (7)

  • Handgrip strength

    At 60 days

  • Up and go test

    At 60 days

  • Six-minute walk test

    6 minutes

  • Two-minute step in place test

    2 minutes

  • Sit-up test

    30 seconds

  • +2 more secondary outcomes

Study Arms (3)

Placebo

PLACEBO COMPARATOR

Beverage without flavonoids

Other: Placebo

No Flavonoids

SHAM COMPARATOR

Beverage with alkalinized cocoa which eliminates flavonoid content

Dietary Supplement: No Flavonoids

Flavonoids

EXPERIMENTAL

Beverage with a flavonoid rich mixture

Other: Flavonoids

Interventions

PlaceboOTHER

Beverage with no flavonoids

Placebo

Flavonoids-enriched cacao beverage

Flavonoids
No FlavonoidsDIETARY_SUPPLEMENT

Beverage with alkalinized cocoa which eliminates flavonoid content

No Flavonoids

Eligibility Criteria

Age55 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sex: both
  • Age: 55-90 yo
  • Waist circumference: Women \> 80 cm, Men \> 90 cm
  • HDL-c: Women \< 50 mg/dL, Men \< 40 mg/dL
  • Triglycerides: ≥ 150 mg/dL
  • Glycemia: ≈100 mg/dL
  • Hand strength: Women\< 20 kg, Men \< 30 kg
  • Up \& Go test: \> 10 seconds
  • Any active infections
  • Malignancies
  • Habitual consumers of antioxidant supplements and cocoa products
  • Use of benzodiazepines or protein supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, Ortiz A, Hidalgo I, Gonzalez C, Meaney E, Villarreal F, Najera N, Ceballos G. High Flavonoid Cocoa Supplement Ameliorates Plasma Oxidative Stress and Inflammation Levels While Improving Mobility and Quality of Life in Older Subjects: A Double-Blind Randomized Clinical Trial. J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1620-1627. doi: 10.1093/gerona/glz107.

MeSH Terms

Conditions

Sarcopenia

Interventions

Flavonoids

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

ChromonesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 16, 2018

First Posted

July 13, 2018

Study Start

January 1, 2017

Primary Completion

October 1, 2017

Study Completion

December 1, 2017

Last Updated

July 13, 2018

Record last verified: 2018-07